Cite
HARVARD Citation
Bridgewater, J. et al. (2016). Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. BMC cancer. 16 (1), p. 1. [Online].